COMBINATION OF ZIBOTENTAN AND DAPAGLIFLOZIN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE AND LIVER FIBROSIS
Application
US20260097057A1
Kind: A1
Apr 09, 2026
Inventors
Philip Ambery
Abstract
Methods for treating chronic kidney disease and liver fibrosis in patients using a fixed-dose combination of zibotentan and dapagliflozin are disclosed.
CPC Classifications
A61K 31/7034
A61K 31/497
A61P 1/16
Filing Date
2025-10-08
Application No.
19352788